DOCSLIB.ORG

Human Microbiome Science

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Human Microbiome Science Ravel et al. Microbiome 2014, 2:16 http://www.microbiomejournal.com/content/2/1/16 MEETING REPORT Open Access Human microbiome science: vision for the future, Bethesda, MD, July 24 to 26, 2013 Jacques Ravel1*, Martin J Blaser2, Jonathan Braun3, Eric Brown4, Frederic D Bushman5, Eugene B Chang6, Julian Davies7, Kathryn G Dewey8, Timothy Dinan9, Maria Dominguez-Bello2, Susan E Erdman10, B Brett Finlay5, Wendy S Garrett11, Gary B Huffnagle12,13, Curtis Huttenhower14, Janet Jansson15, Ian B Jeffery16, Christian Jobin17,18, Alexander Khoruts19, Heidi H Kong20, Johanna W Lampe21, Ruth E Ley22, Dan R Littman23,24, Sarkis K Mazmanian25, David A Mills26,27, Andrew S Neish28, Elaine Petrof29, David A Relman30,31, Rosamond Rhodes32, Peter J Turnbaugh33, Vincent B Young12,13, Rob Knight34 and Owen White35 Abstract A conference entitled ‘Human microbiome science: Vision for the future’ was organized in Bethesda, MD from July 24 to 26, 2013. The event brought together experts in the field of human microbiome research and aimed at providing a comprehensive overview of the state of microbiome research, but more importantly to identify and discuss gaps, challenges and opportunities in this nascent field. This report summarizes the presentations but also describes what is needed for human microbiome research to move forward and deliver medical translational applications. Introduction with diseases, but more importantly, the functional roles Each of us consists of about 40 trillion human cells [1] microbiota play in health and disease. and about 22,000 human genes [2], but as many as 100 trillion microbial cells [3] (the microbiota) and 2 million Meeting goals and objectives microbial genes [4] (the metagenome). Understanding To understand the current state of human microbiome the microbial side of ourselves may therefore be critic- research, and to identify key areas for progress going for- ally important for understanding human biology, includ- ward, we held a conference in Bethesda, MD from July ing drug responses [5-8], susceptibility to infectious [9] 24 to 26, 2013, entitled ‘Human Microbiome Science: and chronic [10] disease, and perhaps even behavior Vision for the Future’. This conference, which was sup- [11]. Since the inception of the Human Microbiome Pro- ported in part from a grant by NIH to the University of ject (HMP) in 2007 [4,12], the fundamental understand- Maryland School of Medicine, together with corporate ing of the human microbiome has grown at an ever sponsors including Roche, Qiagen, Illumina, Life Tech- accelerating pace [13]. Together, the HMP healthy co- nologies, MoBio, Metabolon, and the BioMed Central hort study [14,15], and the many associated studies, journal Microbiome, sought to provide an overview of which provide more details on methodology, bioinfor- cutting-edge work in NIH-supported microbiome re- matics analyses, and additional cohorts, have led to over search, and to identify obstacles as well as opportunities 350 publications (http://www.ploscollections.org/hmp). for progress in this challenging field of research. The This work has set the stage for rapid advances, some meeting was organized by a trans-NIH working group, with high potential for translational studies, in under- including 28 participants (programme staff) from 14 (of standing the mechanisms governing the similarities and the 27) NIH Institutes, Centers and Offices, together differences in the microbes we share, their association with four scientific advisory members funded by the Hu- man Microbiome Project. The meeting was attended by * Correspondence: [email protected] 269 participants (and an additional 250 with webcast) 1 Institute for Genome Sciences, Department of Microbiology and from academia, national labs, a range of government agen- Immunology, University of Maryland School of Medicine, 801 W. Baltimore Street, Baltimore, MD 21201, USA cies including NIH, Environmental Protection Agency Full list of author information is available at the end of the article (EPA), US Department of Agriculture (USDA), Food and © 2014 Ravel et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Ravel et al. Microbiome 2014, 2:16 Page 2 of 11 http://www.microbiomejournal.com/content/2/1/16 Drug Administration (FDA), US Agency for International gastrointestinal diseases and conditions, to cancer and even Development (USAID), Office of Science and Technology mental illnesses. Dr. Eric Green (Director of National Hu- Policy (OSTP), US Army, National Science Foundation man Genome Research Institute, NHGRI) (Figure 1C) (NSF), and National Aeronautics and Space Administra- followed with a report on the state and the many accom- tion (NASA), and involved 37 speakers from a broad plishments of the HMP. The HMP aimed to survey the range of disciplines including microbiology, immunology, microbiome in humans through taxonomic and metage- medicine, infectious disease, ecology, and computer sci- nomic analyses. He highlighted the central healthy cohort ence. The broad expertise of the organizing committee of volunteers who were intensively sampled, and several and the participants underscores the way in which mi- demonstration projects that focused on diseases at sites crobes pervade the human body and our environment, such as the GI track, the skin or the urogenital track. These and microbiome research may soon pervade the biomed- projects generated over 3.5 Tbp of data and 8 million ical research enterprise. unique microbial genes were catalogued. These datasets Over the course of this 3-day meeting, there were pre- (sequence data, strains, clinical phenotypes, nucleic acid ex- sentations and discussions aimed towards: tracts, and even cell lines) are publicly available through re- positories and coordinated through a Data Analysis and – Recognizing that the study of the human Coordination Center (DACC) hosted at the Institute for microbiome, in disease and in health, is of relevance Genome Sciences at the University of Maryland School of to the missions of all NIH Institutes and Centers; Medicine [13]. Overall, the HMP has led to over 350 peer- – Increasing awareness across all NIH Institutes and reviewed scientific publications. The HMP has supported Centers of gaps, needs, and challenges faced by the the development of new bioinformatics and technological broad microbiome research community to drive tools, which altogether facilitate the study of the human future research and investments; microbiome for the scientific community. Human micro- – Facilitating coordination between the NIH Institutes biome studies’ ethical, legal and social implications (ELSI) and Centers to promote coherent oversight for were also evaluated, mirroring the Human Genome Project. policies and approaches that will maximally benefit Dr. David Relman (Stanford University) (Figure 2A) gave microbiome-related biomedical research; thefirstofthreekeynoteaddresseson‘Diversity, Stability – Identifying areas where common resources or and Resilience of the Human Microbiome,’ highlighting the partnerships would benefit microbiome-related bio- larger role the human microbiome plays in both health and medical research; disease. He presented recent work from his laboratory on – Exploring how NIH and other government funding the profound effects of antibiotics in reshaping the human agencies could collaborate to integrate the microbiome, and on the value of applying (and perhaps de- microbiome into studies of human health and more veloping) ecological theory for understanding these com- broadly into studies of human interactions with plex ecosystems and their contributions to human biology their physical and microbial environment; [16]. In particular, he raised the issue of resilience, an – Fostering understanding of the current state of ecological concept that refers to the amount of disturb- microbiome research, and shaping an overall vision ance that a system can withstand without changing its for future directions of the field over the next 10 self-organizing processes or services [17]. He empha- years. sized the need for better tools to define resilience and evaluate the stability of, and harm to human-associated Overview: the human microbiome project microbial communities. In the first session Dr. Owen White (University of Dr. Rosamond Rhodes (Icahn School of Medicine at Maryland School of Medicine, Baltimore, MD, USA) Mount Sinai, New York) discussed the ethical, legal, and (Figure 1A) set the stage for the conference, noting that social implications surrounding the study of the human the meeting was a unique opportunity for microbiome re- microbiome. In particular, she spoke on issues related to searchers both to reflect on past successes and to define the subject identification from knowledge of microbiome se- direction that the field could take going forward. His intro- quence data - issues that are in so many ways analogous duction was followed by a presentation by Dr. Francis to those faced by scientists studying the human genome Collins (Director of the National Institutes of Health, sequence. These issues impact the way microbiome sci-
Load more

Recommended publications
  • CHRISTINA “TINA” WARINNER (Last Updated October 18, 2018)
    CHRISTINA “TINA” WARINNER (last updated October 18, 2018) Max Planck Institute University of Oklahoma for the Science of Human History (MPI-SHH) Department of Anthropology Department of Archaeogenetics Laboratories of Molecular Anthropology Kahlaische Strasse 10, 07743 Jena, Germany And Microbiome Research (LMAMR) +49 3641686620 101 David L. Boren Blvd, [email protected] Norman, OK 73019 USA www.christinawarinner.com [email protected] http://www.shh.mpg.de/employees/50506/25522 www.lmamr.org APPOINTMENTS W2 Group Leader, Max Planck Institute for the Science of Human History, Germany 2016-present University Professor, Friedrich Schiller University, Jena, Germany 2018-present Presidential Research Professor, Univ. of Oklahoma, USA 2014-present Assistant Professor, Dept. of Anthropology, Univ. of Oklahoma, USA 2014-present Adjunct Professor, Dept. of Periodontics, College of Dentistry, Univ. of Oklahoma, USA 2014-present Visiting Associate Professor, Dept. of Systems Biology, Technical University of Denmark 2015 Research Associate, Dept. of Anthropology, Univ. of Oklahoma, USA 2012-2014 Acting Head of Group, Centre for Evolutionary Medicine, Univ. of Zürich, Switzerland 2011-2012 Research Assistant, Centre for Evolutionary Medicine, Univ. of Zürich, Switzerland 2010-2011 EDUCATION Ph.D., Anthropology, Dept. of Anthropology, Harvard University 2010 Thesis Title: “Life and Death at Teposcolula Yucundaa: Mortuary, Archaeogenetic, and Isotopic Investigations of the Early Colonial Period in Mexico” A.M., Anthropology, Dept. of Anthropology, Harvard University 2008 B.A., with Honors, Anthropology, University of Kansas 2003 B.A., Germanic Literatures and Languages, University of Kansas 2003 SELECTED HONORS, AWARDS, AND FELLOWSHIPS Invited speaker, British Academy, Albert Reckitt Archaeological Lecture (forthcoming) 2019 Invited speaker, EMBL Science and Society (forthcoming, Nov.
    [Show full text]
  • Ayshwarya Subramanian Updated June 10, 2021
    Ayshwarya Subramanian Updated June 10, 2021 Contact Kuchroo Lab and Klarman Cell Observatory Information Broad Institute twitter: @ayshwaryas 5407G, 415 Main Street website: ayshwaryas.github.io Cambridge, MA 02412 USA email:[email protected] Areas of Computational Biology (Kidney disease, Cancer, Inflammatory Bowel Disease, RNA Biology), Ge- expertise nomic Data Analysis (Single-cell and Bulk-RNAseq, Metagenomics, Exome and single-nucleus DNA sequencing), Machine Learning, Probabilistic modeling, Phylogenetics, Applied Statistics Education 2013 Ph.D., Biological Sciences Carnegie Mellon University, Pittsburgh, PA USA Doctoral Advisor: Russell Schwartz, Ph.D. Dissertation: Inferring tumor evolution using computational phylogenetics 2007 M.Sc. (Hons), Biological Sciences (Undergraduate degree) Birla Institute of Technology and Science (BITS{Pilani), Rajasthan, India CGPA 9.21/10, Major GPA 10/10, with Distinction Undergraduate Honors Thesis: A mathematical model for phototactic responses in Halobac- terium salinarium, Max Planck Institute for Complex Technical Systems, Germany. Current Computational Scientist, Cambridge MA 2017{Present Appointment Mentors: Aviv Regev, Ph.D. & Vijay Kuchroo, Ph.D., D.V.M Research Summary: Single-cell portraits of disease and normal states using human data, mouse and organoid models Klarman Cell Observatory Broad Institute, Cambridge, MA 02142 Publications Pre-prints/Under review [1] Subramanian A†, Vernon KA†, Zhou Y† et al. Obesity-instructed TREM2high macrophages identified by comparative analysis of diabetic mouse and human kidney at single cell resolution. bioRxiv 2021.05.30.446342; doi: https://doi.org/10.1101/2021.05.30.446342. [2] Subramanian A†,Vernon KA†, Slyper M, Waldman J, et al. RAAS blockade, kidney dis- ease, and expression of ACE2, the entry receptor for SARS-CoV-2, in kidney epithelial and endothelial cells.
    [Show full text]
  • Case Studies in Bayesian Statistics Workshop 9 Poster Session
    Case Studies in Bayesian Statistics Workshop 9 Poster Session Following is a tentative list of posters being presented during the workshop: 1. Edoardo Airoldi, Curtis Huttenhower, Olga Troyanskaya and David Botstein 2. Dipankar Bandyopadhyay, Elizabeth Slate, Debajyoti Sinha, Dikpak Dey and Jyotika Fernandes 3. Brenda Betancourt and Maria-Eglee Perez 4. Sham Bhat, Murali Haran, Julio Molineros and Erick Dewolf 5. Jen-hwa Chu, Merlise A. Clyde and Feng Liang 6. Jason Connor, Scott Berry and Don Berry 7. J. Mark Donovan, Michael R. Elliott and Daniel F. Heitjan 8. Elena A. Erosheva, Donatello Telesca, Ross L. Matsueda and Derek Kreager 9. Xiaodan Fan and Jun S. Liu 10. Jairo A. Fuquene and Luis Raul Pericchi 11. Marti Font, Josep Ginebra, Xavier Puig 12. Isobel Claire Gormley and Thomas Brendan Murphy 13. Cari G. Kaufman and Stephan R. Sain 14. Alex Lenkoski 15. Herbie Lee 16. Fei Liu 17. Jingchen Liu, Xiao-Li Meng, Chih-nan Chen, Margarita Alegria 18. Christian Macaro 19. Il-Chul Moon, Eunice J. Kim and Kathleen M. Carley 20. Christopher Paciorek 21. Susan M. Paddock and Patricia Ebener 22. Nicholas M. Pajewski, L. Thomas Johnson, Thomas Radmer, and Purushottam W. Laud 23. Mark W. Perlin, Joseph B. Kadane, Robin W. Cotton and Alexander Sinelnikov 24. Alicia Quiros, Raquel Montes Diez and Dani Gamerman 25. Eiki Satake and Philip Amato 26. James Scott 27. Russell Steele, Robert Platt and Michelle Ross 28. Alejandro Villagran, Gabriel Huerta, Charles S. Jackson and Mrinal K. Sen 29. Dawn Woodard 30. David C. Wheeler, Lance A. Waller and John O.
    [Show full text]
  • UNIVERSITY of CALIFORNIA SAN DIEGO Making Sense of Microbial
    UNIVERSITY OF CALIFORNIA SAN DIEGO Making sense of microbial populations from representative samples A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Computer Science by James T. Morton Committee in charge: Professor Rob Knight, Chair Professor Pieter Dorrestein Professor Rachel Dutton Professor Yoav Freund Professor Siavash Mirarab 2018 Copyright James T. Morton, 2018 All rights reserved. The dissertation of James T. Morton is approved, and it is acceptable in quality and form for publication on microfilm and electronically: Chair University of California San Diego 2018 iii DEDICATION To my friends and family who paved the road and lit the journey. iv EPIGRAPH The ‘paradox’ is only a conflict between reality and your feeling of what reality ‘ought to be’ —Richard Feynman v TABLE OF CONTENTS Signature Page . iii Dedication . iv Epigraph . .v Table of Contents . vi List of Abbreviations . ix List of Figures . .x List of Tables . xi Acknowledgements . xii Vita ............................................. xiv Abstract of the Dissertation . xvii Chapter 1 Methods for phylogenetic analysis of microbiome data . .1 1.1 Introduction . .2 1.2 Phylogenetic Inference . .4 1.3 Phylogenetic Comparative Methods . .6 1.4 Ancestral State Reconstruction . .9 1.5 Analysis of phylogenetic variables . 11 1.6 Using Phylogeny-Aware Distances . 15 1.7 Challenges of phylogenetic analysis . 18 1.8 Discussion . 19 1.9 Acknowledgements . 21 Chapter 2 Uncovering the horseshoe effect in microbial analyses . 23 2.1 Introduction . 24 2.2 Materials and Methods . 34 2.3 Acknowledgements . 35 Chapter 3 Balance trees reveal microbial niche differentiation . 36 3.1 Introduction .
    [Show full text]
  • Curriculum Vitae
    Kamhawi S., 1 CURRICULUM VITAE NAME: Shaden Kamhawi, Ph.D. h index 2014, 29 ADDRESS Vector Molecular Biology Section Laboratory of Malaria and Vector Research National Institute of Allergy and Infectious Diseases National Institutes of Health 12735 Twinbrook Parkway Room 2E-32D Rockville, MD, 20852 Phone: 301-594-5547 Fax: 301-594-5373 Email: [email protected] PROFESSIONAL EXPERIENCE 2014-Present, Associate Scientist, Core, Laboratory of Malaria and Vector Research (LMVR), NIAID, NIH 2006-2014, Staff Scientist, Core, Laboratory of Malaria and Vector Research (LMVR), NIAID, NIH 2001- 2006, Staff Scientist, Laboratory of Parasitic Diseases (LPD), NIAID, NIH. 1997- 2001, Visiting associate, LPD, NIAID, NIH. 1996- 2000, Associate professor, Department of Biological Sciences, Yarmouk University, Irbid, Jordan. 1990-1996, Assistant professor, Department of Biological Sciences, Yarmouk University, Irbid, Jordan. EDUCATION 1990, Ph.D. in Medical Entomology, Salford Univeristy, Salford, England. 1985, B.Sc. in Biological & Biochemical Sciences, Salford University, Salford, England. AREA OF EXPERTISE Vector Biology; Vector-Parasite-Host molecular interactions; Host immune response to transmission of Leishmania by sand fly bite; Development of vector-based vaccines; Field-oriented investigations of epidemiology of leishmaniases and transmission patterns. CURRENT DUTIES: Dr. Kamhawi plays an essential role in sand fly-related research at NIAID. She brings a unique set of skills including extensive field expertise in leishmaniasis epidemiology and Kamhawi S., 2 a proficiency in experimental techniques covering various fields including entomology, parasitology, immunology and molecular biology. Current duties of Dr. Kamhawi include: The sand fly Unit: Dr. Kamhawi is a world expert on phlebotomine sand flies, vectors of the neglected tropical disease leishmaniasis.
    [Show full text]
  • Bioinformatics Opening Workshop September 8 - 12, 2014
    Bioinformatics Opening Workshop September 8 - 12, 2014 Mihye Ahn James (Paul) Brooks University of North Carolina Virginia Commonwealth Alexander Alekseyenko Greg Buck New York University Virginia Commonwealth Baiguo An Mark Burch University of North Carolina Ohio State University Jeremy Ash Christopher Burke North Carolina State University University of Cincinnati Deepak Nag Ayyala Hongyuan Cao University of Maryland University of Missouri Keith Baggerly Vincent Carey MD Anderson Center Harvard University Veera Baladandayuthapani Luis Carvalho MD Anderson Center Boston University Pallavi Basu Alberto Cassese University of Southern California Rice University Munni Begum Changgee Chang Ball State University Emory University Emanuel Ben-David Hegang Chen Columbia University University of Maryland Anindya Bhadra Chen Chen Purdue University Purdue University Yuanyuan Bian Mengjie Chen University of Missouri University of North Carolina Huybrechts Frazier Achard Bindele Hyoyoung Choo-Wosoba University of South Alabama University of Louisville Kristen Borchert Pankaj Choudhary BD Technologies University of Texas Russell Bowler Hyonho Chun National Jewish Health Purdue University Bioinformatics Opening Workshop September 8 - 12, 2014 Robert Corty Yang Feng University of North Carolina Columbia University Xinping Cui Hua Feng University of California, Riverside University of Idaho Hongying Dai Jennifer Fettweis Children's Mercy Hospital Virginia Commonwealth Susmita Datta Dayne Filer University of Louisville EPA Sujay Datta Christopher Fowler
    [Show full text]
  • The NIH Human Microbiome Project Authors: the NIH HMP Working Group (
    Downloaded from genome.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press The NIH Human Microbiome Project Authors: the NIH HMP Working Group (http://nihroadmap.nih.gov/hmp/members.asp) ABSTRACT: The Human Microbiome Project ( HMP), funded as an initiative of the NIH Roadmap for Biomedical Research (http://nihroadmap.nih.gov), is a multi-component community resource. The goals of the HMP are (1) to take advantage of new, high-throughput technologies to characterize the human microbiome more fully by studying samples from multiple body sites from each of at least 250 “normal” volunteers; (2) to determine whether there are associations between changes in the microbiome and health/disease by studying several different medical conditions; and (3) to provide both a standardized data resource and new technological approaches to enable such studies to be undertaken broadly in the scientific community. The ethical, legal, and social implications of such research are being systematically studied as well. The ultimate objective of the HMP is to demonstrate that there are opportunities to improve human health through monitoring or manipulation of the human microbiome. The history and implementation of this new program are described here. INTRODUCTION: It has been known for some time that the human body is inhabited by at least ten times more bacteria than the number of human cells in the body, and that the majority of those bacteria are found in the human gastrointestinal tract (Savage 1977). Throughout the history of microbiology, most human studies have focused on the disease-causing organisms found on or in people; fewer studies have examined the benefits of the resident bacteria.
    [Show full text]
  • Integrating Taxonomic, Functional, and Strain-Level Profiling of Diverse
    TOOLS AND RESOURCES Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3 Francesco Beghini1†, Lauren J McIver2†, Aitor Blanco-Mı´guez1, Leonard Dubois1, Francesco Asnicar1, Sagun Maharjan2,3, Ana Mailyan2,3, Paolo Manghi1, Matthias Scholz4, Andrew Maltez Thomas1, Mireia Valles-Colomer1, George Weingart2,3, Yancong Zhang2,3, Moreno Zolfo1, Curtis Huttenhower2,3*, Eric A Franzosa2,3*, Nicola Segata1,5* 1Department CIBIO, University of Trento, Trento, Italy; 2Harvard T.H. Chan School of Public Health, Boston, United States; 3The Broad Institute of MIT and Harvard, Cambridge, United States; 4Department of Food Quality and Nutrition, Research and Innovation Center, Edmund Mach Foundation, San Michele all’Adige, Italy; 5IEO, European Institute of Oncology IRCCS, Milan, Italy Abstract Culture-independent analyses of microbial communities have progressed dramatically in the last decade, particularly due to advances in methods for biological profiling via shotgun metagenomics. Opportunities for improvement continue to accelerate, with greater access to multi-omics, microbial reference genomes, and strain-level diversity. To leverage these, we present bioBakery 3, a set of integrated, improved methods for taxonomic, strain-level, functional, and *For correspondence: phylogenetic profiling of metagenomes newly developed to build on the largest set of reference [email protected] (CH); sequences now available. Compared to current alternatives, MetaPhlAn 3 increases the accuracy of [email protected] (EAF); taxonomic profiling, and HUMAnN 3 improves that of functional potential and activity. These [email protected] (NS) methods detected novel disease-microbiome links in applications to CRC (1262 metagenomes) and †These authors contributed IBD (1635 metagenomes and 817 metatranscriptomes).
    [Show full text]
  • Continuous Chromatin State Feature Annotation of the Human Epigenome
    bioRxiv preprint doi: https://doi.org/10.1101/473017; this version posted November 18, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Continuous chromatin state feature annotation of the human epigenome Bowen Chen, Neda Shokraneh Kenari, Maxwell W Libbrecht∗ School of Computing Science, Simon Fraser University, Burnaby BC, Canada Abstract Semi-automated genome annotation (SAGA) methods are widely used to understand genome activity and gene regulation. These methods take as input a set of sequencing-based assays of epigenomic activity (such as ChIP-seq measurements of histone modification and transcription factor binding), and output an annotation of the genome that assigns a chromatin state label to each genomic position. Existing SAGA methods have several limitations caused by the discrete annotation framework: such annotations cannot easily represent varying strengths of genomic elements, and they cannot easily represent combinatorial elements that simultaneously exhibit multiple types of activity. To remedy these limitations, we propose an annotation strategy that instead outputs a vector of chromatin state features at each position rather than a single discrete label. Continuous modeling is common in other fields, such as in topic modeling of text documents. We propose a method, epigenome-ssm, that uses a Kalman filter state space model to efficiently annotate the genome with chromatin state features. We show that chromatin state features from epigenome-ssm are more useful for several downstream applications than both continuous and discrete alternatives, including their ability to identify expressed genes and enhancers.
    [Show full text]
  • Download the Print Version of Inside Stanford
    The Precision Health and Integrated Diagnostics Center aims STANFORD to prevent healthy people from becoming ill. INSIDE Page 4 Volume 10, No.MEDICINE 10 May 21, 2018 Published by the Office of Communication & Public Affairs Multigene tests for breast cancer on the rise STEVE FISCH By Krista Conger he use of genetic tests aimed at detecting the pres- ence of mutations in the BRCA1 and BRCA2 Tgenes in women with breast cancer is rapidly de- clining in favor of tests that can detect multiple cancer- associated mutations, according to researchers at the School of Medicine and five other U.S. medical centers. Some researchers had wondered whether multigene testing, which may identify genetic mutations of un- certain clinical significance, would lead more women to consider prophylactic mastectomies — a surgery in which both breasts are removed to prevent future can- cers — out of an abundance of caution. However, the current study did not show an increase in mastectomies associated with testing more genes. The shift reflects a growing acknowledgement by clinicians that multigene panel tests can yield more clinically useful information for patients and their unaf- fected relatives, the researchers said. Overall, multigene panels were about twice as likely as the tests for BRCA1 and BRCA2 to identify disease- associated genetic variants, the study found. However, multigene testing was more likely than the BRCA-only testing to be delayed until after surgery to remove the tumor. This time lag may limit a patient’s treatment op- tions, the researchers said. ‘Becoming the norm’ “In general, multigene panel tests yield more clinically useful results and are rapidly becoming the norm,” Allison Kurian said.
    [Show full text]
  • Mechanisms to the Human in Life Body
    FROM DEFENSE BACTERIA MECHANISMS TO THE HUMAN IN LIFE BODY FOURTEENTH ANNUAL LSI SYMPOSIUM MAY 21, 2015 Images courtesy of Katherine D. Walton, research investigator, and Deborah Gumucio, professor, Department of Cell and Developmental Biology, U-M Medical School SCHEDULE FORUM HALL, PALMER COMMONS (OVERFLOW SEATING AVAILABLE IN GREAT LAKES NORTH) 8:30 A.M. 1:15 P.M. WELCOME | Alan Saltiel, Ph.D. ROLE OF THE MICROBIOTA IN INFECTION CONTROL Mary Sue Coleman Director of the Life Sciences Institute AND SEQUELAE | Yasmine Belkaid, Ph.D. Chief of Mucosal Immunology Section, Laboratory of 8:35 A.M. Parasitic Diseases, National Institutes of Health, National INTRODUCTION OF THE MARY SUE AND KENNETH Institute of Allergy and Infectious Diseases COLEMAN LIFE SCIENCES LECTURER | Mary Sue Coleman, Ph.D. 1:55 P.M. President Emerita IMMUNE REGULATION OF INTESTINAL HEALTH AND DISEASE | Gregory F. Sonnenberg, Ph.D. 8:50 A.M. Assistant Professor of Microbiology and Immunology in MARY SUE AND KENNETH COLEMAN LIFE SCIENCES Medicine, Weill Cornell Medical College LECTURE: HOMEOSTASIS, INFLAMMATION AND DISEASE | Ruslan Medzhitov, Ph.D. AFTERNOON BREAK David W. Wallace Professor of Immunobiology, Yale School of Medicine; Investigator, Howard Hughes 3:15 P.M. Medical Institute TISSUE CONTROL OF MACROPHAGE HOMEOSTASIS AND FUNCTION | Miriam Merad, M.D., Ph.D. MORNING BREAK Professor of Oncological Science and Medicine; Mount Sinai Chair in Cancer Immunology; Director of Human 10:30 A.M. Immune Monitoring Center, Tisch Cancer Institute, Icahn GENERATION OF A MEMORY OF INFECTION DURING School of Medicine at Mount Sinai CRISPR-CAS IMMUNITY | Luciano Marraffini, Ph.D. Assistant Professor, head of the Laboratory of 3:55 P.M.
    [Show full text]
  • 18Th Annual Upstate New York Immunology Conference
    20152015 18th Annual Upstate New York Immunology Conference Major Corporate Sponsors: BD Biosciences BioLegend, Inc. Taconic Bioscience Keynote Speakers: Supported by Yasmine Belkaid, Ph.D. NIH/NIAID Kristin A. Hogquist, Ph.D. Grant Funding Workshop Presentation by: Yasmine Belkaid, Ph.D. Jacob Schumacher, AAI AAI Young Investigator Awards eBioscience/affymetrix Trainee Travel Awards Welcome to The Sagamore Resort and Conference Center Bolton Landing, NY October 25-28, 2015 2. UPSTATE NEW YORK IMM UNOLOGY CONFERENCE ( NYIC) We’ve come a long way from Garnet Hill! This meeting started in 1997 as a small retreat to facilitate interactions among young scientists, institutions, and renowned experts in the field of Immunology. In just a few short years, the number of attendees grew and a larger venue was needed to meet the future needs of the Conference. We are happy to announce the American Association of Immu- nologists (AAI) is once again providing 10 Young Investigator Awards. eBioscience is also proving 10 Trainee Travel Awards. All award winners will give Oral Poster Presentations. There will also be two Workshops. Keynote speakers are Dr. Yasmine Belkaid (NIH/NIAID) and Dr. Kristin A. Hogquist (University of Minnesota). As part of our leisure activities, there will be a cruise on Lake George, as well as a recreational night including miniature golf, Wii, X-box, whiffle ball, and movies! Mr. Brown’s Pub will be open Tuesday night for informal discussions. Trainees will also have an opportunity to win an iPad during one of two drawings. You must be present at the drawing to win! While all these elements lend to the atmosphere, one simple principle goal of this Conference re- mains.
    [Show full text]